INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

Title:

INSULIN ANALOG HAVING REDUCED BINDING FORCE TO INSULIN RECEPTOR, AND USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2018/056764

Kind Code:

A1

Abstract:

The present invention relates to a novel insulin analog, use thereof, and a method for preparing the same analog.

More Like This:

WO/2001/000675	PROTAMINE-FREE INSOLUBLE ACYLATED INSULIN COMPOSITIONS
WO/1982/003394	THERAPEUTICALLY ACTIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
WO/1998/037910	PEPTIDE INHBITORS OF PROPEPTIDE/PROHORMONE CONVERTASES

Inventors:

CHOI IN YOUNG (KR)
JUNG SUNG YOUB (KR)
KORN MARCUS (DE)
GUESSREGEN STEFAN (DE)
TENNAGELS NORBERT (DE)

Application Number:

PCT/KR2017/010504

Publication Date:

March 29, 2018

Filing Date:

September 22, 2017

Export Citation:

Assignee:

HANMI PHARM IND CO LTD (KR)
SANOFI AVENTIS DEUTSCHLAND (DE)

International Classes:

C07K14/62; A61K38/28; C07K1/12; C07K1/18; C07K1/20; C12N15/70; C12P21/00

Foreign References:

Other References: